A BREAKTHROUGH HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and developing AIDS should be made...
Vous n'êtes pas connecté
A BREAKTHROUGH HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and developing AIDS should be made available “immediately” at pharmacies, clinics and via Online consultations, the UN health agency said recently. Injectable lenacapavir, LEN for short, is a highly effective, long-acting antiretroviral alternative to […]
A BREAKTHROUGH HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and developing AIDS should be made...
The World Health Organisation (WHO) on Monday released a landmark policy, recommending the use of injectable Lenacapavir (LEN) twice a year as an...
Cambodia becomes Asia's second nation to launch long-acting injectable PrEP for HIV prevention, marking strong progress toward ending AIDS.
A breakthrough HIV drug that only needs...
A breakthrough HIV drug that only needs...
By Jeremy Fregene A major breakthrough in HIV prevention has been achieved, as the World Health Organisation (WHO) has endorsed lenacapavir (LEN), a...
By Jeremy Fregene A major breakthrough in HIV prevention has been achieved, as the World Health Organisation (WHO) has endorsed lenacapavir (LEN), a...
Cambodia is now the second country in Asia, following Thailand, to initiate long-acting injectable medlinkpre-exposure prophylaxis (PrEP)/medlink to...
GENEVA, Switzerland – The World Health Organization (WHO) released new guidelines recommending the use of injectable lenacapavir (LEN) twice a...
The director-general of the World Health Organisation (WHO), Tedros Ghebreyesus, has endorsed new WHO guidelines recommending long-acting injectable...